GlassScriptPhysician profile
Michael B Digiacomo
NPI 1821389958
$998.17
in general payments reported to CMS, 2019-2025
16 companies · $96.57 in 2025
The $96.57 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $102 · 2021: $135 · 2022: $168 · 2023: $102 · 2024: $145 · 2025: $96.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $142.68 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $135.73 | 2021-2025 | Entyvio |
| Chiesi USA, INC. | $114.79 | 2019-2022 | |
| Bone Support INC. | $111.24 | 2024 | Cerament G, Ceramentbone Void Filler |
| Comsort, INC | $100.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.32 | 2019-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $85.10 | 2019-2023 | Bridion |
| Janssen Biotech, INC. | $81.63 | 2019-2025 | Tremfya, Stelara |
| Avanos Medical | $28.64 | 2019 | |
| Ardelyx, INC. | $17.81 | 2025 | Ibsrela |
| Qol Medical, LLC | $16.79 | 2023 | Sucraid |
| Pacira Pharmaceuticals Incorporated | $14.71 | 2024 | Exparel, Iovera |
| Heron Therapeutics, INC. | $14.56 | 2022 | |
| Baudax Bio INC. | $13.63 | 2020 | |
| Genzyme Corporation | $12.59 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Digiacomo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.